BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 28199963)

  • 1. Long non-coding RNA HULC as a potential prognostic biomarker in human cancers: a meta-analysis.
    Fan YH; Wu MJ; Jiang Y; Ye M; Lu SG; Wu L; Zhu XG
    Oncotarget; 2017 Mar; 8(13):21410-21417. PubMed ID: 28199963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA CCAT2 can predict metastasis and poor prognosis: A meta-analysis.
    Fan YH; Fang H; Ji CX; Xie H; Xiao B; Zhu XG
    Clin Chim Acta; 2017 Mar; 466():120-126. PubMed ID: 28089750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA activated by TGF-β in human cancers: A meta-analysis.
    Fan YH; Ji CX; Xu B; Fan HY; Cheng ZJ; Zhu XG
    Clin Chim Acta; 2017 May; 468():10-16. PubMed ID: 28163033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA HOTTIP as an independent prognostic marker in cancer.
    Fan Y; Yan T; Chai Y; Jiang Y; Zhu X
    Clin Chim Acta; 2018 Jul; 482():224-230. PubMed ID: 28778381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Value of lncRNA HULC as a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis.
    Chen X; Lun L; Hou H; Tian R; Zhang H; Zhang Y
    Cell Physiol Biochem; 2017; 41(4):1424-1434. PubMed ID: 28315877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Significance of Long Non-coding RNA HULC in Predicting Prognosis and Metastasis of Cancers: a Meta-Analysis.
    Ding Y; Sun C; Li J; Hu L; Li M; Liu J; Pu L; Xiong S
    Pathol Oncol Res; 2019 Jan; 25(1):311-318. PubMed ID: 29110261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and clinical significance of long non-coding RNA HNF1A-AS1 in solid cancers: A systematic review and meta-analysis.
    Zhou X; Fan YH; Wang Y; Liu Y
    Medicine (Baltimore); 2019 Dec; 98(49):e18264. PubMed ID: 31804362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TUG1, SPRY4-IT1, and HULC as valuable prognostic biomarkers of survival in cancer: A PRISMA-compliant meta-analysis.
    Zhong Y; Chen Z; Guo S; Liao X; Xie H; Zheng Y; Cai B; Huang P; Liu Y; Zhou Q; Liu Y; Huang W
    Medicine (Baltimore); 2017 Nov; 96(46):e8583. PubMed ID: 29145271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AlncRNA HULC as an effective biomarker for surveillance of the outcome of cancer: A meta-analysis.
    Chen X; Lin J; Liu Y; Peng J; Cao Y; Su Z; Wang T; Cheng J; Hu D
    PLoS One; 2017; 12(2):e0171210. PubMed ID: 28146578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF-activated lncRNA predicts gastrointestinal cancer patient prognosis: a meta-analysis.
    Fan YH; Ye MH; Wu L; Wu MJ; Lu SG; Zhu XG
    Oncotarget; 2017 Jan; 8(4):6295-6303. PubMed ID: 28009984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA TUG1 as a potential prognostic biomarker in human cancers: a meta-analysis.
    Ma PJ; Guan QK; Meng L; Qin N; Zhao J; Jin BZ
    Oncotarget; 2017 Sep; 8(37):62454-62462. PubMed ID: 28977959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Non-Coding RNA SPRY4-IT1 Can Predict Unfavorable Prognosis and Lymph Node Metastasis: a Meta-Analysis.
    Li N; Tan Q; Jing W; Luo P; Tu J
    Pathol Oncol Res; 2017 Oct; 23(4):731-736. PubMed ID: 28054316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA HULC as a potential predictor of prognosis and clinicopathological features in patients with digestive system tumors: a meta-analysis.
    Li D; Wang R; Wu N; Yu Y
    Aging (Albany NY); 2022 Feb; 14(4):1797-1811. PubMed ID: 35183058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA CRNDE as a potential prognostic biomarker in solid tumors: A meta-analysis.
    Liang C; Zhang B; Ge H; Xu Y; Li G; Wu J
    Clin Chim Acta; 2018 Jun; 481():99-107. PubMed ID: 29501692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA CYTOR in cancer: A TCGA data review.
    Liang J; Wei X; Liu Z; Cao D; Tang Y; Zou Z; Zhou C; Lu Y
    Clin Chim Acta; 2018 Aug; 483():227-233. PubMed ID: 29750962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
    Zhang S; Qiu D; Xie X; Shen Y
    BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-Coding RNA HOXA Transcript at the Distal Tip as a Putative Biomarker of Metastasis and Prognosis: a Meta-Analysis.
    Liu FT; Xue QZ; Zhang Y; Hao TF; Luo HL; Zhu PQ
    Clin Lab; 2016 Nov; 62(11):2091-2098. PubMed ID: 28164662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA CCAT2 can predict metastasis and a poor prognosis: A meta-analysis.
    Jing X; Liang H; Cui X; Han C; Hao C; Huo K
    Clin Chim Acta; 2017 May; 468():159-165. PubMed ID: 28263738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA PANDAR as a prognostic marker in Chinese cancer.
    Ma PJ; Guan QK; Xu DW; Zhao J; Qin N; Jin BZ
    Clin Chim Acta; 2017 Dec; 475():172-177. PubMed ID: 29066211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.